-
1 week ago | 
bioprocessonline.com | Lucia Fernandez |Lucia Fernández |Dan Brownell |Junwei Sun
By Lucia Fernandez, Ph.D., Dan Brownell, and Junwei Sun
VintaBio employs a proprietary HEK293 clone, VintaCell™, optimized for growth in fixed-bed bioreactors, alongside a chemically defined transfection reagent, VintaFect™, to support scalable and cost-effective AAV vector production. These components are integrated into VintaProcess™, a unique manufacturing platform that uses a proprietary perfusion system with media recirculation to enhance vector yield and consistency.
-
2 weeks ago | 
bioprocessonline.com | Junwei Sun |Lucia Fernandez |Lucia Fernández |Matthew Ercolino |Jonathan Rocher
Take a tour of Nanoform's best-in-class nanodevelopment capabilities, setting new standards in innovation. Their highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. With 14 development lines for small molecules and 5 for large molecules, Nanoform offers unmatched scalability and precision. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers.
-
3 weeks ago | 
cellandgene.com | ajaz Hussain |Junwei Sun |Lucia Fernandez |Lucia Fernández |Matthew Ercolino
Pharmaceutical sovereignty is no longer a theoretical concern. Sovereignty in this context does not imply isolation, but rather strategic resilience: building robust national and regional capabilities that ensure security while enabling global collaboration. Utilizing Quantitative PCR For The Assessment Of AAV SheddingExplore AAV shedding assessment using qPCR, featuring experts discussing assay development, monitoring challenges, and ensuring safety in clinical studies.
-
1 month ago | 
bioprocessonline.com | Nero Haralalka |Junwei Sun |Lucia Fernandez |Lucia Fernández |Matthew Ercolino
Multispecific molecules bring added complexity to downstream purification—think incorrect chain pairings, aggregation, fragmentation, and lower yields. Join Bioprocess Online Live as we explore how developers are addressing these challenges to achieve high purity and efficient processes. Gain insights into key considerations for downstream teams when designing purification strategies for these advanced biologics. Registration is free thanks to the support of Thermo Fisher Scientific.
-
1 month ago | 
cellandgene.com | Nero Haralalka |Junwei Sun |Lucia Fernandez |Lucia Fernández |Matthew Ercolino
The ISCT 2025 Scientific Annual Meeting (May 7-10 in New Orleans) is the largest global gathering for KOLs and subject matter experts for driving the clinical translation of cell and gene therapies. The work presented at this conference spans regulatory affairs, workforce development and the entire development pathway from pre-clinical work to Phase 3 clinical trials, CGT product launch and market access.
-
2 months ago | 
bioprocessonline.com | Pooja Sharma |Junwei Sun |Lucia Fernandez |Lucia Fernández |Matthew Ercolino
Webinar: Minimizing your Risk in RNA-lipid Nanoparticle (LNP) Encapsulation and Drug Product Manufacturing Through a Holistic ApproachJoin us on March 31st to discover how Lonza's platform-based strategy ensures stability, efficacy, and quality in LNP Drug Products with nucleic acid payloads. Learn about critical process challenges in encapsulation, filtration, and aseptic filling, and how to proactively mitigate risks for successful GMP batch manufacturing.
-
2 months ago | 
bioprocessonline.com | Junwei Sun |Lucia Fernandez |Lucia Fernández |Matthew Ercolino |Stephen Aiken
Webinar: Harnessing AI, Spatial Transcriptomics & Mass Spectrometry for Clinical InsightsThis webinar covers how preserving spatial molecular information enhances tissue analysis. It explores spatial-Omics platforms, AI models predicting treatment responses, and identifying patient subgroups. Topics include spatial-omics integration, AI-driven predictions, oncology applications, and improving molecular signatures for personalized medicine. Click here to learn more.
-
Mar 6, 2025 | 
cellandgene.com | Ankitkumar Patel |Junwei Sun |Lucia Fernandez |Lucia Fernández |Matthew Ercolino
Webinar: Who’s In Charge of Your Trial? How to Ensure Effective Oversight and LeadershipClinical trials in complex therapeutic areas require more than just a solid strategy—they demand proactive and engaged operational leadership from the sponsor side. Join our expert panel to discuss how an active and knowledgeable Clin Ops lead, in collaboration with an experienced outsourcing project lead, can drive informed decision-making, enhance efficiency, and ultimately ensure trial success.
-
Jan 27, 2025 | 
cellandgene.com | Elben Guimaraes |Xiaojun Liu |Junwei Sun |Lucia Fernandez |Lucia Fernández
Each approach has its advantages and drawbacks. This guide should help you decide which one, or perhaps a hybrid strategy, is best for your company. Exploring Strategies For Developing Robust AAV PlatformsExplore advanced AAV production platforms that enhance efficiency, scalability, and compliance, paving the way for safe and accessible gene therapies.
-
Jan 13, 2025 | 
cellandgene.com | Steve Kornher |Shanti Chari |Junwei Sun |Lucia Fernandez |Lucia Fernández
With over 450 unique products in clinical development and 50 anticipated approvals by 2030, the evolving regulatory landscape for cell and gene therapies is more critical than ever. Don't miss your chance to gain expert insights! Join the next Cell & Gene Live for an exclusive digital panel discussion exploring forward-looking perspectives on this transformative field. Registration is free—thanks to the support of Thermo Fisher Scientific.
